Brexit's Disruptive Impact On U.K. And European Prescription Drug Market

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 15, 2019 at 11:42 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via In brief, a no-deal Brexit would imply an unprecedented disruption of the European pharmaceuticals market in terms of research, regulation, manufacture, and trade in biopharmaceuticals. It would even impact drug prices as reference pricing schemes throughout the E.U. would need to be altered.

    article source